Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial (Q34625239)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial
scientific article

    Statements

    Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial (English)
    Antonio Carolei
    Gary A Ford
    Mark W Parsons
    Peter A Ringleb
    Gregory G Schwartz
    Lawrence H Young
    IRIS Trial investigators
    823-9.e6

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit